Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

For Staff

Communications, branding and engagement

Find out about editing your website profile, get presentation templates,  and more. Here.

SOCIAL MEDIA

Join us on Facebook and Twitter.

intranet

Our new intranet has been launched. You can find relevant information on finance, HR, our working culture, buildings, communications, and latest news and updates.  You can also go here for room bookings, Health & Safety information, etc.

Latest news

TCRs drive CARs

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer treatments. This study, published in Cell, demonstrates that engineering T-cells to express both a Chimeric Antigen Receptor (CAR) and a T-cell Receptor (TCR) can improve their ability to distinguish between cancerous and healthy tissues—addressing a major challenge in current immunotherapy.

Common virus may improve skin cancer treatment outcomes, study finds

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence how skin cancer patients respond to current treatments.

CRUK funding for research into earlier detection of relapse in people with multiple myeloma

Dr Karthik Ramasamy and team will assess a new mass spectrometry-based monitoring technique for its ability to predict and identify early disease relapse.

New ultrasound drug delivery system found to be highly effective against bacterial biofilms

Researchers at the University of Oxford have developed a new drug delivery system using ultrasound-activated nanoparticles to break through and destroy bacterial biofilms. This offers a promising solution that could address the global crisis of chronic antibiotic-resistant infections affecting hundreds of millions of people worldwide.